Searched for
ZIPRASIDONE
Cadila Healthcare surges on USFDA approval of antipsychotic drugThe scrip touched an intraday high and low of Rs 484.60 and Rs 465.75 respectively, in the first hour of trade.- Market Now: MTNL, Globus Spirits among stocks that surged over 10% todayAmong the IT gainers, Infosys led, followed by KPIT, Just Dial and Tech Mahindra.
- Indian drugmakers switching to fresh strategies as US amends normsIndian generic drug producers are devising fresh strategies to continue benefiting from the world’s largest pharmaceutical market the Unite...
- Dr Reddy's Laboratories Q4 net up 67% at Rs 571 croreDr Reddy's Laboratories today reported a 66.58 per cent rise in its net profit to Rs 570.89 crore for the quarter ended March 31, 2013.
- US, Indian markets main drivers of growth in Q4: Nilesh Gupta, LupinIn the US, there are some products like Ziprasidone, Fortamet and products that we introduced like Tricor have been doing very well for the...
- Wockhardt gets tentative USFDA nod for anti-psychotic drugPharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psycho...
- Launch of anti-HIV drug Combivir generic a positive development for LupinThe launch of Combivir generic is a positive development for Lupin. However, it will have to share the mkt with competitors viz. Teva & Aur...
- Dr Reddy's launches Ziprasidone Hydrochloride capsules in USDr Reddy's Laboratories announced today that it has launched Ziprasidone Hydrochloride Capsules, a bioequivalent generic version of Geodon,...
- Dr Reddy's launches generic version of Pfizer's Geodon capsules in US marketDr Reddy's Lab said it has launched a generic version of Pfizer's Geodon capsules in the US market, used in treating mental disorders.
- Lupin receives USFDA nod for anti-psychotic drugDomestic pharma company Lupin Ltd on Monday said it has received tentative approval from the US Food and Drug Administration (USFDA) for it...
Load More
